Phage-specific diverse effects of bacterial viruses on the immune system

References

• 1. Crunkhorn S. Phage therapy for Mycobacterium abscessus. Nat. Rev. Drug Discov. 18(7), 500 (2019).
  Google Scholar
• 2. Aslam S, Courtwright AM, Koval C et al. Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. Am. J. Transplant. doi:10.1111/ajt.15503 (2019) (Epub ahead of print).
  MedlineGoogle Scholar
• 3. Dedrick RM, Guerrero-Bustamante CA, Garlena RA et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25(5), 730–733 (2019).
  Medline CASGoogle Scholar
• 4. Górski A, Międzybrodzki R, Węgrzyn G et al. Phage therapy: current status and perspectives. Med. Res. Rev. doi:10.1002/med.21593 (2019) (Epub ahead of print).
  MedlineGoogle Scholar
• 5. Górski A, Jończyk-Matysiak E, Międzybrodzki R et al. Phage therapy: beyond antibacterial action. Front. Med. 5, 146 (2018).
  Google Scholar
• 6. Górski A, Ważna E, Weber-Dąbrowska B et al. Bacteriophage translocation. FEMS Immunol. Med. Microbiol. 46, 313–319 (2006).
  Medline CASGoogle Scholar
• 7. Nguyen S, Baker K, Padman BS et al. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. MBio 8(6), e01874-17 (2017).
  Google Scholar
• 8. Sweere JM, Van Belleghem JD, Ishak H et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science 363(6434), pii:eaat9691 (2019).
  MedlineGoogle Scholar
• 9. Dąbrowska K, Miernikiewicz P, Piotrowicz A et al. Immunogenicity studies of proteins forming the T4 phage head surface. J. Virol. 88(21), 12551–12557 (2014).
  MedlineGoogle Scholar
• 10. Żaczek M, Łusiak-Szelachowska M, Jończyk-Matysiak E et al. Antibody production in response to staphylococcal MS-1 phage cocktail in patients undergoing phage therapy. Front. Microbiol. 24(7), 1681 (2016).
  Google Scholar
• 11. Dąbrowska K, Zembala M, Boratyński J et al. Hoc protein regulates the biological effects of T4 phage in mammals. Arch. Microbiol. 187, 489–498 (2007).
  Medline CASGoogle Scholar
• 12. Górski A, Międzybrodzki R, Borysowski J et al. Phage as a modulator of immune responses: practical implications for phage therapy. Adv. Virus Res. 83, 41–47 (2012).
  Medline CASGoogle Scholar
• 13. Van Belleghem JD, Clement F, Merabishvili M et al. Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci. Rep. 7(1), 8004 (2017).
  MedlineGoogle Scholar
• 14. Przybylski M, Dzieciątkowski T, Borysowski J et al. Inhibitory effects of bacteriophage preparations on adenoviral replication. Intervirology 62(1), 37–44 (2019).
  Medline CASGoogle Scholar
• 15. Sela U, Euler CW, Correa da Rosa J et al. Strains of bacterial species induce a greatly varied acute adaptive immune response: the contribution of the accessory genome. PLoS Pathog. 14(1), e1006726 (2018).
  MedlineGoogle Scholar
• 16. Dufour N, Delattre R, Chevallereau A et al. Phage therapy of pneumonia is not associated with an over stimulation of the inflammatory response compared to antibiotic treatment in mice. Antimicrob. Agents Chemother. doi:10.1128/AAC.00379-19 (2019) (Epub ahead of print).
  MedlineGoogle Scholar
• 17. Pincus NB, Reckhow JD, Saleem D et al. Strain specific phage treatment for Staphylococcus aureus infection is influenced by host immunity and site of infection. PLoS ONE 10(4), e0124280 (2015).
  MedlineGoogle Scholar
• 18. Borysowski J, Przybylski M, Międzybrodzki R et al. The effects of bacteriophages on the expression of genes involved in antimirobial immunity. Adv. Hyg. Exp. Med. 73, 414–420 (2019).
  Google Scholar
• 19. Cha K, Oh HK, Jang JY et al. Characterization of two novel bacteriophages infecting multidrug-resistant (MDR) Acinetobacter baumannii and evaluation of their therapeutic efficacy in vivo. Front. Microbiol. 9, 696 (2018).
  MedlineGoogle Scholar
• 20. Stocki P, Wang XN, Dickinson AM. Inducible heat shock protein 70 reduces T cell responses and stimulatory capacity of monocyte-derived dendritic cells. J. Biol. Chem. 287(15), 12387–12394 (2012).
  Medline CASGoogle Scholar
• 21. Spierings J, Van Eden W. Heat shock proteins and their immunomodulatory role in inflammatory arthritis. Rheumatology (Oxford) 56(2), 198–208 (2017).
  Medline CASGoogle Scholar
• 22. Międzybrodzki R, Borysowski J, Kłak M et al. In vivo studies on the influence of bacteriophage preparations on the autoimmune inflammatory process. Biomed. Res. Int. 2017, 3612015 (2017).
  MedlineGoogle Scholar
• 23. Luo X, Zuo X, Mo X et al. Treatment with recombinant Hsp72 suppresses collagen-induced arthritis in mice. Inflammation 34(5), 432–439 (2011).
  Medline CASGoogle Scholar
• 24. Górski A, Dąbrowska K, Międzybrodzki R et al. Phages and immunomodulation. Future Microbiol. 12, 905–914 (2017).
  CASGoogle Scholar
• 25. Pruzzo C, Debbia EA, Satta G. Identification of the major adherence ligand of Klebsiella pneumoniae in the receptor for coliphage T7 and alteration of Klebsiella adherence properties by lysogenic conversion. Infect. Immun. 30(2), 562–571 (1980).
  Medline CASGoogle Scholar
• 26. Lehti TA, Pajunen MI, Skog MS et al. Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells. Net. Commun. 8(1), 1915 (2017).
  MedlineGoogle Scholar
• 27. Drake PM, Nathan JK, Stock CM et al. Polysialic acid, a glycan with highly restricted expression, is found on human and murine leukocytes and modulates immune responses. J. Immunol. 181(10), 6850–6858 (2008).
  Medline CASGoogle Scholar
• 28. Villanueva-Cabello TM, Gutierrez-Valenzuela LD, Lopez-Guerrero DV et al. Polysialic acid is expressed in human naïve CD4⁺ T cells and is involved in modulating activation. Glycobiology 29(7), 557–564 (2019).
  Medline CASGoogle Scholar
• 29. Vitiello CL, Merril CR, Adhya S. An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. Virus Res. 114(1–2), 101–103 (2005).
  Medline CASGoogle Scholar